Tanaka, T.; Suzuki, H.; Ohishi, T.; Kaneko, M.K.; Kato, Y.
A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Cells 2024, 13, 1833.
https://doi.org/10.3390/cells13221833
AMA Style
Tanaka T, Suzuki H, Ohishi T, Kaneko MK, Kato Y.
A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Cells. 2024; 13(22):1833.
https://doi.org/10.3390/cells13221833
Chicago/Turabian Style
Tanaka, Tomohiro, Hiroyuki Suzuki, Tomokazu Ohishi, Mika K. Kaneko, and Yukinari Kato.
2024. "A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models" Cells 13, no. 22: 1833.
https://doi.org/10.3390/cells13221833
APA Style
Tanaka, T., Suzuki, H., Ohishi, T., Kaneko, M. K., & Kato, Y.
(2024). A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Cells, 13(22), 1833.
https://doi.org/10.3390/cells13221833